Pharmaceutical

Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal

Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.

May 29, 2024 - 04:00
Helsinn and Angelini Pharma renew AULIN and MESULID distribution deal
Helsinn Group has renewed an agreement with Angelini Pharma for the commercialisation of AULIN and MESULID.
Read the original article

Tags:

Previous Article

Asahi Kasei offers to buy Sweden’s Calliditas for $1.04bn

Next Article

QUT team receives US DoD funding for Parkinson’s treatment

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: ‘Internist’ is a confusing, outdated term. It’s time for a new name

Opinion: ‘Internist’ is a confusing, outdated term. It’...

Apr 13, 2023

Sosei Heptares hits discovery milestone in GPCR deal with Genentech

Sosei Heptares hits discovery milestone in GPCR deal wi...

Oct 31, 2023

STAT+: Diabetes treatments have improperly listed patents that should be removed, analysis finds

STAT+: Diabetes treatments have improperly listed paten...

Feb 5, 2024